DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
85 hedge funds and large institutions have $380M invested in DermTech, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 7 closing their positions.
529% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 7
217% more capital invested
Capital invested by funds: $120M → $380M (+$260M)
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
77% more funds holding
Funds holding: 48 → 85 (+37)
50% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 12
6% less call options, than puts
Call options by funds: $3.96M | Put options by funds: $4.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$11.2M |
| 2 |
ICM
ISZO Capital Management
New York
|
+$6.74M |
| 3 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$6.38M |
| 4 |
BM
Bridger Management
New York
|
+$2.56M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$2.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$5.09M |
| 2 |
MS
Maven Securities
St Helier,
Jersey
|
-$3.61M |
| 3 |
FA
Friess Associates
Greenville,
Delaware
|
-$2.8M |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$2.7M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.73M |
DMTK Hedge Fund Activity: Q4 2020 in Review
85 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q4 2020, worth a combined $380M — up 217% from $120M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new DMTK positions and 7 closed out — a net gain of 37 holders — while 18 added to existing stakes and 12 trimmed.
The largest buyer was Ameriprise, opening a new position worth an estimated $11.2M. The largest seller was Farallon Capital Management, cutting an estimated $5.09M.
- 85 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q4 2020, up from 48 in Q3 2020.
- Funds reported $380M of DermTech, Inc. Common Stock stock for Q4 2020, up 217% quarter-over-quarter.
- 44 funds opened new DermTech, Inc. Common Stock positions in Q4 2020 and 7 closed out, a net change of +37 holders.
- The largest DermTech, Inc. Common Stock buyer in Q4 2020 was Ameriprise, an estimated $11.2M added.
- The largest DermTech, Inc. Common Stock seller in Q4 2020 was Farallon Capital Management, an estimated $5.09M sold.
Based on aggregated 13F filings for Q4 2020.